MedShape said today it inked a deal to divest its ExoShape ACL fixation system properties to ConMed (NSDQ:CNMD) for an undisclosed amount. The deal, which closed on Monday, includes Atlanta-based MedShape’s ExoShape femoral and tibial soft tissue fasteners designed to fixate soft tissue grafts in anterior cruciate ligament reconstructive surgery. “The ExoShape system has represented a […]
Zimmer Biomet (NYSE:ZBH) subsidiary Cayenne Medical buried the hatchet with MedShape after a patent review board found the terms of its soft tissue anchor patent to be “indefinite.” Cayenne sued MedShape in 2014, alleging infringement by MedShape’s ExoShape device of 2 of its patents covering the AperFix soft tissue anchor. The lawsuit, filed in the U.S. District Court for Arizona, […]
Cayenne Medical filed a lawsuit against rival MedShape Inc., alleging infringement of 2 of its patents covering its AperFix soft tissue anchor by MedShape’s ExoShape device.
The lawsuit, filed in the U.S. District Court for Arizona, alleges that MedShape hired former Cayenne salespeople with knowledge of the 2 patents at issue, which cover Cayenne’s AperFix device.
MedShape said it won 510(k) clearance from the FDA for its ExoShape femoral soft tissue fastener, a shape memory polymer device used in knee reconstruction procedures.
The Atlanta-based medical device company touts the ExoShape implant, for anterior cruciate ligament reconstruction surgeries, as "the only femoral fixation device fabricated completely out of PEEK Altera polymer," according to a press release.
MedShape Inc. said it raised $11 million to advance its pipeline of shape memory devices.
The Atlanta-based medical device company said the proceeds will go toward "further development and commercialization of pipeline products," including the launch of its Eclipse soft tissue anchor.
That device won 510(k) clearance from the FDA in March.